Year To Quarter End Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7716453

Concept 2018-06-01 to
2018-11-30
2017-06-01 to
2017-11-30
Year to quarter end statement of income
Statement of income
Net sales
20,145,447,000 JPY
20,454,187,000 JPY
Cost of sales
15,747,599,000 JPY
16,223,145,000 JPY
Gross profit (loss)
4,397,848,000 JPY
4,231,042,000 JPY
Selling, general and administrative expenses
2,071,179,000 JPY
1,967,677,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
2,327,736,000 JPY
2,265,504,000 JPY
Non-operating income
Interest income
216,000 JPY
2,143,000 JPY
Dividend income
39,604,000 JPY
38,573,000 JPY
Non-operating income
60,245,000 JPY
63,095,000 JPY
Non-operating expenses
Interest expenses
10,748,000 JPY
13,892,000 JPY
Non-operating expenses
19,284,000 JPY
24,156,000 JPY
Ordinary profit (loss)
2,368,697,000 JPY
2,304,443,000 JPY
Extraordinary income
Extraordinary income
56,980,000 JPY
20,524,000 JPY
Extraordinary losses
Extraordinary losses
0 JPY
292,000 JPY
Profit (loss) before income taxes
2,425,677,000 JPY
2,324,676,000 JPY
Income taxes
750,036,000 JPY
752,628,000 JPY
Profit (loss)
1,675,640,000 JPY
1,572,047,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.